Nevertheless, these women have up to an 80% risk of developing breast or ovarian cancer by age 70 compared to women carrying two wild-type copies of BRCA1, due to the appearance of additional deleterious mutations within the wild-type BRCA1 allele in their somatic breast cells (Narod and Foulkes, 2004). This evidence concerns the gene BRCA1 and ovarian carcinoma.